Bioequivalence Study of Morphine Sulfate 60 mg Extended-Release Tablets Under Fed Conditions

Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers

NCT00864968 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects

NCT06168929 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers

NCT02181907 ·Status: COMPLETED ·Phase: PHASE1

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

NCT01618903 ·Status: COMPLETED ·Phase: PHASE1

Evaluate Bioequivalence of Burotam (1/1 g/Vial)

NCT05654090 ·Status: UNKNOWN ·Phase: PHASE4

Bioequivalence Study of CJ-30059

NCT02173912 ·Status: UNKNOWN ·Phase: PHASE1

Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Volunteers Under Fed Condition

NCT04445922 ·Status: UNKNOWN ·Phase: PHASE1

Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers

NCT02263989 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions

NCT06823362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects

NCT02821338 ·Status: COMPLETED ·Phase: PHASE1

Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects

NCT01396590 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions

NCT01155089 ·Status: COMPLETED ·Phase: NA

Concor® Bioequivalence Study in Chinese Participants (Darmstadt-Nantong)

NCT05930808 ·Status: COMPLETED ·Phase: PHASE1

Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)

NCT00945035 ·Status: COMPLETED ·Phase: PHASE1

Study to Demonstrate the Bioequivalence of Single Oral Administration of K-001 Relative to Single Oral Coadministration of Separate Tablets of K-877-ER and CSG452

NCT05722262 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions

NCT00893958 ·Status: COMPLETED ·Phase: NA

A Pharmacokinetic and Bioequivalence Study of Savolitinib Tablets in Healthy Chinese Male Volunteers

NCT03860948 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"

NCT04671316 ·Status: COMPLETED ·Phase: PHASE1

Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose

NCT06428903 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of CJ-30060 in Healthy Volunteers

NCT03757390 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects

NCT03796013 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions

NCT00759902 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fed Conditions

NCT01634399 ·Status: COMPLETED ·Phase: PHASE1

A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

NCT02596100 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male Subjects

NCT06678542 ·Status: COMPLETED ·Phase: PHASE1